张晔, 杨斌, 白同, 高英堂, 刘辉, 骆莹, 王鹏, 杜智. 丹参酮ⅡA对肝癌细胞系SMMC-7721去甲基化作用的研究[J]. 中国肿瘤临床, 2011, 38(8): 421-425 . DOI: 10.3969/j.issn.1000-8179.2011.08.001
引用本文: 张晔, 杨斌, 白同, 高英堂, 刘辉, 骆莹, 王鹏, 杜智. 丹参酮ⅡA对肝癌细胞系SMMC-7721去甲基化作用的研究[J]. 中国肿瘤临床, 2011, 38(8): 421-425 . DOI: 10.3969/j.issn.1000-8179.2011.08.001

丹参酮ⅡA对肝癌细胞系SMMC-7721去甲基化作用的研究

  • 摘要: 目的:探讨丹参酮ⅡA对肝癌细胞SMMC-7721抑癌基因的去甲基化作用。方法: 将肝癌细胞系SMMC-7721分组培养, 丹参酮组和5-氮-2'脱氧胞苷组分别在培养液中加入上述两种药物, 阴性对照组不加药物。经培养后, 应用甲基化特异性PCR方法检测细胞TFPI2、 SPARC、 DKK3、 p16、 APC、 MGMT基因启动子区的甲基化状态。应用亚硫酸盐修饰测序法对培养后3组细胞提取的DNA进行测序, 比较各组细胞SPARC基因启动子区CpG位点的甲基化差异。通过逆转录PCR、 免疫细胞化学染色检测基因的表达。结果: TFPI2、 p16及APC在SMMC-7721细胞中呈部分甲基化状态, 而SPARC、 DKK3及MGMT呈完全甲基化状态。经丹参酮ⅡA或5-氮-2'脱氧胞苷作用后, 两组细胞SPARC、 DKK3及MGMT基因可检测到非甲基化状态, 逆转录PCR可检测到这些基因的mRNA表达, 免疫细胞化学染色可检测到SPARC的蛋白表达, 而对照组细胞未检测到相应基因表达。对SPARC的亚硫酸盐修饰测序显示, 对照组、 5-氮-2'脱氧胞苷组和丹参酮组细胞的CpG甲基化频率分别为96.53% (139/144)、 18.75 % (27/144) 和45.14% (65/144), 各组间比较均有统计学差异 (P<0.001)。定量逆转录PCR检测DNA甲基转移酶Ⅰ的相对表达, 丹参酮组较对照组下调至36%~78%。结论: 丹参酮ⅡA可逆转SMMC-7721细胞部分抑癌基因的甲基化状态, 恢复基因表达, 其可能通过下调DNA甲基转移酶Ⅰ的表达而影响细胞DNA的甲基化过程。

     

    Abstract: Demethylation Effects of TanshinoneⅡA on SMMC-7721 CellsYe ZHANG, Bin YANG, Tong BAI, Yingtang GAO, Hui LIU, Ying LUO, PengWANG, Zhi DUCorrespondence to: Zhi DU, E-mail: zhi-du@163.comThe Third Central Hospital of Tianjin, Tianjin Key Laboratory of Artificial Cell, Tianjin 300170, ChinaThis study was supported by Tianjin Health Bureau Funded Project (No. 2010KZ17 and 09KY04)Abstract Objective: To investigate the demethylation effects of tanshinoneⅡA on tumor suppressor genes of hepatocellularcarcinoma cells. Methods: SMMC-7721 cells were devided into three groups during the culture course in vitro. In tanshinone ⅡAgroup, cells were treated with tanshinoneⅡA at different doses in the culture media. Cells in the positive control group were cultured inthe media with 5-Aza-2'-deoxycytidine at 10 μmol/L. Cells in the negative group were cultured with blank media. The methylationstatus of tumor suppressor gene profile including TFPI2, SPARC, DKK3, P16, APC and MGMT was analyzed in different groups bymethylation-specific polymerase chain reaction ( PCR ). The mRNA expression of genes was examined by reverse transcription PCRand the protein expression was tested by immunocytochemistry staining. By bisulfite sequencing, methylation status of CpG sites inSPARC promoter region was estimated in different groups. Results: Both methylated and unmethylated status of TFPI2, P16 and APCcould be detected in the three groups by methylation-specific PCR. In the negative control group, methylated segments of SPARC,DKK3 and MGMT were only detected, however, both methylated and unmethylated segments of these genes were found in tanshinoneⅡA group and 5-Aza-2'-deoxycytidine group. SPARC, DKK3 and MGMT were totally methylated while TFPI2, P16 and APC werepartially methylated in SMMC-7721 cells. The mRNA expression of SPARC, DKK3 and MGMT could be restored in tanshinoneⅡAgroup compared with negative control group. Immunocytochemistry showed positive expression of SPARC in tanshinoneⅡA group.Methylation frequencies of CpG sites in SPARC promoter region were 96.53% (139/144) in the negative control group, 18.75% ( 27/144 ) in 5-Aza-2'-deoxycytidine group and 45.14% ( 65/144 ) in tanshinoneⅡA group, respectively. There was a significant differencein methylation frequencies of CpG sites among the three groups ( P < 0.001 ). Parts of methylated CpGs were converted tounmethylation status in both tanshinoneⅡA group and 5-Aza-2'-deoxycytidine group. Compared with that in the negative controlgroup, the mRNA expression of DNA methytransferaseⅠwas downregulated by 0.36-0.78 folds in tanshinoneⅡA group. Conclusion:TanshinoneⅡA might convert the methylation status of some tumor suppressor genes in SMMC-7721 cells by downregulating DNAmethytransferaseⅠ.Keywords Hepatocellular carcinoma; Tumor suppressor gene; Methylation; TanshinoneⅡA

     

/

返回文章
返回